SSY GROUP (02005) announced that the company has obtained the drug production registration approval from China's National Medical Products Administration for Acetylcysteine Injection (25ml: 5g). Classified as a Category 3 chemical drug, it is considered to have passed the consistency evaluation, making SSY GROUP the third domestic company to receive approval for this product. Acetylcysteine Injection is primarily used for detoxification in cases of acute acetaminophen poisoning and to prevent or mitigate liver damage caused by overdose.
Additionally, the group has secured approval from the National Medical Products Administration for Compound Sodium Acetate Ringer's Injection (500ml), also classified as a Category 3 chemical drug and deemed to have passed the consistency evaluation. Compound Sodium Acetate Ringer's Injection is mainly used for replenishing extracellular fluid in cases of reduced circulating blood volume and interstitial fluid, as well as correcting metabolic acidosis.
Comments